Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

710 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A digest from evidence-based Clinical Practice Guideline for Polycystic Kidney Disease 2020.
Nishio S, Tsuchiya K, Nakatani S, Muto S, Mochizuki T, Kawano H, Hanaoka K, Hidaka S, Ichikawa D, Ishikawa E, Uchiyama K, Koshi-Ito E, Hayashi H, Makabe S, Ogata S, Mitobe M, Sekine A, Suwabe T, Kataoka H, Kai H, Kaneko Y, Kurashige M, Seta K, Shimazu K, Hama T, Miura K, Nakanishi K, Horie S, Furuichi K, Okada H, Narita I; Committee of Clinical Practical Guideline for Polycystic Kidney Disease 2020. Nishio S, et al. Among authors: narita i. Clin Exp Nephrol. 2021 Dec;25(12):1292-1302. doi: 10.1007/s10157-021-02097-6. Epub 2021 Sep 26. Clin Exp Nephrol. 2021. PMID: 34564792 No abstract available.
Pretreatment plasma intact parathyroid hormone and serum calcium levels, but not serum phosphate levels, predict the response to maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism.
Oyama Y, Kazama JJ, Omori K, Higuchi N, Kameda S, Yamamoto S, Ito Y, Maruyama H, Narita I, Gejyo F. Oyama Y, et al. Among authors: narita i. Clin Exp Nephrol. 2005 Jun;9(2):142-7. doi: 10.1007/s10157-005-0342-2. Clin Exp Nephrol. 2005. PMID: 15980949 Clinical Trial.
[Clinical nephrology].
Kaneko Y, Narita I, Gejyo F. Kaneko Y, et al. Among authors: narita i. Nihon Jinzo Gakkai Shi. 2007;49(1):19-24. Nihon Jinzo Gakkai Shi. 2007. PMID: 17299980 Japanese. No abstract available.
Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease.
Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Hara S, Ura N, Kiyohara Y, Hirakata H, Watanabe T, Moriyama T, Ando Y, Inaguma D, Narita I, Iso H, Wakai K, Yasuda Y, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S. Imai E, et al. Among authors: narita i. Clin Exp Nephrol. 2007 Mar;11(1):41-50. doi: 10.1007/s10157-006-0453-4. Epub 2007 Mar 28. Clin Exp Nephrol. 2007. PMID: 17384997
Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient.
Imai E, Horio M, Iseki K, Yamagata K, Watanabe T, Hara S, Ura N, Kiyohara Y, Hirakata H, Moriyama T, Ando Y, Nitta K, Inaguma D, Narita I, Iso H, Wakai K, Yasuda Y, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S. Imai E, et al. Among authors: narita i. Clin Exp Nephrol. 2007 Jun;11(2):156-163. doi: 10.1007/s10157-007-0463-x. Epub 2007 Jun 28. Clin Exp Nephrol. 2007. PMID: 17593516
Design and methods of a strategic outcome study for chronic kidney disease: Frontier of Renal Outcome Modifications in Japan.
Yamagata K, Makino H, Akizawa T, Iseki K, Itoh S, Kimura K, Koya D, Narita I, Mitarai T, Miyazaki M, Tsubakihara Y, Watanabe T, Wada T, Sakai O; Advisory Committee for FROM-J. Yamagata K, et al. Among authors: narita i. Clin Exp Nephrol. 2010 Apr;14(2):144-51. doi: 10.1007/s10157-009-0249-4. Epub 2009 Dec 18. Clin Exp Nephrol. 2010. PMID: 20020312 Clinical Trial.
710 results